Table 3.
Characteristic | N (%) or alternative parameter | ||
---|---|---|---|
Total no. of isolates included | 2275 | ||
Total no. of patients included | 1970 | ||
Age (median, IQR) | 65 years (47 – 77yrs) | ||
Male sex (no., %) | 1063 (56·8%) | ||
Sample collected for clinical purposes (suspected infection) | 1428 (62·8%) | ||
Sample collected for MDRO screening purposes | 847 (37·2%) | ||
Time from admission to isolate collection (median, IQR) | 3 days (1 – 12 days) |
Ward where sample was collected | All samples (% total samples) | Clinical samples (% per ward) | Screening samples (% per ward) |
---|---|---|---|
Intensive care unit | 373 (16·4%) | 117 (31·4%) | 256 (68·6%) |
Other high-risk warda | 434 (19·1%) | 121 (27·9%) | 313 (72·1%) |
General acute wardb | 1090 (47·9%) | 865 (79·4%) | 225 (20·6%) |
Emergency department | 209 (9·2%) | 204 (97·6%) | 5 (2·4%) |
Subacute care wardc | 169 (7·4%) | 121 (71·6%) | 48 (28·4%) |
MDRO, multidrug-resistant organism; IQR, interquartile range.
High-risk wards, includes haematology, oncology, renal ward (including renal transplant), and liver transplant wards.
General acute wards, include all wards not designated as ICU, high-risk or subacute.
Subacute care, includes aged care, rehabilitation, palliative care and spinal wards.